MAAT INDEX
Rankings
90.0 /100

Altria Group (MO)

CONSUMER DEFENSIVE · 62 verified grades · · BalancedBIASMedian signed deviation across numeric graded claims. Sandbags: outcomes land favorable to guidance. Overpromises: the opposite. Needs at least 6 numeric claims.

Verify independently: SEC filings ↗

What management is on the hook for (118)

hedged · expects · high conviction
2026 Q3 (8)8 open
OPENVERDICTDeadline not reached yet; the claim is still on the clock.CONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
So we're excited about the 12-milligram national launch in the third quarter.
Test pending
made Jul 30, 2026 · for Q3 FY26
OPENVERDICTDeadline not reached yet; the claim is still on the clock.CONVICTIONStated expectation · “we expect”, “should”, “we see”
We have not announced the timing of when we plan to re-enter the category, but we do plan on re-entering that category.
Test pending
made Jul 30, 2026 · due Jul 30, 2027
OPENVERDICTDeadline not reached yet; the claim is still on the clock.CONVICTIONStated expectation · “we expect”, “should”, “we see”
Our plan is to re-enter the market at some point with NJOY ACE.
Test pending
made Jul 30, 2026 · due Jul 30, 2027
OPENVERDICTDeadline not reached yet; the claim is still on the clock.CONVICTIONStated expectation · “we expect”, “should”, “we see”
We believe increased enforcement activity, including supply-related disruptions at the border is helping slow demand for illicit products.
Test pending
made Jul 30, 2026 · due Dec 31, 2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.CONVICTIONStated expectation · “we expect”, “should”, “we see”
Helix also plans to introduce flavor extensions across 6, 9 and 12-milligram strengths, beginning with Blueberry Mint and Mango Pineapple in the fourth quarter.
Test pending
made Jul 30, 2026 · for Q4 FY2025
OPENVERDICTDeadline not reached yet; the claim is still on the clock.CONVICTIONStated expectation · “we expect”, “should”, “we see”
We do expect in the second half of the year for export volume to increase, and we'll have a more balanced benefit across Q3 and Q4 for the FET credit.
Test pending
made Jul 30, 2026 · for H2 FY26
OPENVERDICTDeadline not reached yet; the claim is still on the clock.CONVICTIONStated expectation · “we expect”, “should”, “we see”
And while refunds of taxes and duties paid on imported cigarettes for the quarter were flat sequentially due to timing factors, we continue to expect export volume and related tax refunds to be higher in the second half of the year with a more balanced benefit across the third and fourth quarters.
Test pending
made Jul 30, 2026 · for H2 FY26
OPENVERDICTDeadline not reached yet; the claim is still on the clock.CONVICTIONStated expectation · “we expect”, “should”, “we see”
We now expect to deliver adjusted diluted EPS in a range of $5.61 to $5.72, representing a growth rate of 3.5% to 5.5% from a base of $5.42 in 2025.
Test pending
eps · made Jul 30, 2026 · for FY2025
2026 Q2 (6)6 open
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.productCONVICTIONStated expectation · “we expect”, “should”, “we see”
Cow Boyd Cut, we will expand distribution later in the year, specifically later in the second quarter.
Test pending
made Apr 30, 2026 · due Jun 30, 2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.marginsCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
You will see increases in the export volume and the benefit of the duty drawback as the year progresses.
WHAT TO LOOK FOR
Duty drawback benefit recognized (and/or export volume), quarter over quarter
Duty drawback benefit in Q2 2026 higher than Q1 2026, and Q3 2026 higher than Q2 2026 (sequential increases each quarter) SourceWHERE TO FIND ITCompany quarterly earnings release / 10-Q management discussion on duty drawback and export volume

KNOWABLE AFTER2026-12-31
made Apr 30, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
We reaffirm our expectation to deliver 2026 full year adjusted diluted EPS and in a range of $5.56 to $5.72, representing a growth rate of 2.5% to 5.5% and from a base of $5.42 in 2025.
WHAT TO LOOK FOR
Full year adjusted diluted EPS, fiscal year 2026
Adjusted diluted EPS between $5.56 and $5.72 SourceWHERE TO FIND ITCompany earnings release / 10-K adjusted EPS disclosure (Q4 2026 / FY2026 results)

KNOWABLE AFTER2027-02-15
eps · made Apr 30, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.regulationCONVICTIONStated expectation · “we expect”, “should”, “we see”
We believe the science and evidence supporting all of these applications is compelling and provides a basis for FDA authorization within the 180-day statutory time line.
WHAT TO LOOK FOR
FDA authorization status for on! PLUS applications (Mint, Wintergreen, Tobacco 12mg strengths, and the 6 additional varieties) under the pilot program
FDA grants marketing authorization (or otherwise completes action) on the on! PLUS applications within 180 days of submission/acceptance SourceWHERE TO FIND ITFDA public database of authorized tobacco/nicotine pouch products, company press releases, or management commentary on quarterly earnings calls

KNOWABLE AFTER2026-10-27
made Apr 30, 2026 · due Oct 27, 2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
Our reaffirmed guidance range now contemplates the impact of moderated labor industry growth on combustible and e-vapor product volumes and increased macroeconomic uncertainty facing adult nicotine consumers.
WHAT TO LOOK FOR
Full year 2026 adjusted diluted EPS
Adjusted diluted EPS between $5.56 and $5.72 SourceWHERE TO FIND ITCompany earnings release / 10-K full year 2026 results

KNOWABLE AFTER2027-02-15
made Apr 30, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
As a result of the strong first quarter performance, we now expect 2026 adjusted diluted EPS growth to be more balanced between the first half and the second half of the year.
WHAT TO LOOK FOR
First-half 2026 adjusted diluted EPS growth rate vs second-half 2026 adjusted diluted EPS growth rate (year-over-year, each vs corresponding prior-year period)
H1 2026 adjusted diluted EPS growth rate and H2 2026 adjusted diluted EPS growth rate are within roughly 3 percentage points of each other (i.e., no longer heavily skewed toward second-half growth as previously guided) SourceWHERE TO FIND ITCompany quarterly earnings releases and adjusted diluted EPS reconciliations (Q2 2026 and Q4/full-year 2026 releases)

KNOWABLE AFTER2027-01-31
eps · made Apr 30, 2026 · for FY2026
2026 Q1 (5)5 open
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
So yes, we expect some elevated investments upfront as you get more volume through the import-export process.
Test pending
made Jan 29, 2026 · due Jun 30, 2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.pricingCONVICTIONStated expectation · “we expect”, “should”, “we see”
As far as ON PLUS pricing, while I'll be careful not to play out our whole strategy, we do believe ON PLUS is a differentiated product and commands a premium in the marketplace.
WHAT TO LOOK FOR
ON PLUS retail list price relative to ON Classic list price
ON PLUS price per can/unit listed higher than ON Classic price per can/unit SourceWHERE TO FIND ITnicotine.com pricing pages / company retail pricing disclosures

KNOWABLE AFTER2026-12-31
made Jan 29, 2026 · due Dec 31, 2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.otherCONVICTIONStated expectation · “we expect”, “should”, “we see”
Our guidance contemplates planned investments to support our contract manufacturing capabilities, limited impact on combustible and e-vapor product volumes from illicit enforcement efforts, and NJOY ACE not returning to the marketplace in 2026.
WHAT TO LOOK FOR
Full-year 2026 adjusted diluted EPS
Between $5.56 and $5.72 SourceWHERE TO FIND ITCompany earnings release / 10-K adjusted diluted EPS disclosure

KNOWABLE AFTER2027-01-31
made Jan 29, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
We expect growth to be weighted to the second half of the year, reflecting a progressive increase in cigarette import and export activity over the course of the year.
WHAT TO LOOK FOR
Adjusted diluted EPS growth (YoY), first half 2026 vs second half 2026
Second-half 2026 adjusted diluted EPS growth rate (vs 2H2025) greater than first-half 2026 adjusted diluted EPS growth rate (vs 1H2025) SourceWHERE TO FIND ITCompany quarterly earnings releases (Q1-Q4 2026 adjusted diluted EPS, MO investor relations)

KNOWABLE AFTER2027-02-15
eps · made Jan 29, 2026 · for H2 FY26
OPENVERDICTDeadline not reached yet; the claim is still on the clock.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
We anticipate Helix will continue to be profitable for the full year 2026.
WHAT TO LOOK FOR
Helix segment full-year operating income (profitability) for fiscal year 2026
Helix segment full-year 2026 operating income > $0 SourceWHERE TO FIND ITCompany segment reporting (10-K / Q4 2026 earnings release, Helix/oral nicotine pouches segment results)

KNOWABLE AFTER2027-02-15
made Jan 29, 2026 · for FY2026
2025 Q4 (4)4 open
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
We feel really good about the ability to narrow guidance by raising the bottom.
Test pending
eps · made Oct 30, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
We expect EPS growth to moderate in the fourth quarter as we lap the lower share count associated with the 2024 accelerated share repurchase program and the benefit of the MSA legal fund expiration.
Test pending
eps · made Oct 30, 2025 · due Dec 31, 2025
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
Our ambition is the goal. We haven't changed our goals from an overall CAGR that we stated previously. And that's been our stated goal. So yes, that's the way I would think about how we're going to manage the business going forward.
WHAT TO LOOK FOR
Adjusted diluted EPS CAGR over the multi-year period referenced (previously stated as mid-single-digit)
Multi-year adjusted EPS CAGR >= 4% (mid-single-digit range, approximately 4-6%) SourceWHERE TO FIND ITCompany-disclosed adjusted diluted EPS figures (10-K / earnings releases) across the stated multi-year period

KNOWABLE AFTER2028-12-31
eps · made Oct 30, 2025 · for long-term
OPENVERDICTDeadline not reached yet; the claim is still on the clock.regulationCONVICTIONStated expectation · “we expect”, “should”, “we see”
We do not expect a final determination from the ITC before early 2027 and intend to vigorously defend our positions in this litigation.
WHAT TO LOOK FOR
Timing of ITC final determination in JUUL v. NJOY patent infringement case
No final ITC determination issued before 2027-02-28 SourceWHERE TO FIND ITITC public case docket / company litigation disclosures (10-K/10-Q)

KNOWABLE AFTER2027-02-28
made Oct 30, 2025 · for by early 2027
2025 Q3 (5)5 open
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
While tariffs have had an impact on our cost, we don't view them as material to our overall business, and they have been contemplated in the guidance that we have provided you.
Test pending
made Jul 30, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
I think when you think about on!, I'll be careful not to lay out exactly what we're going to do in the second half. But you see the success that we've had through the first half, we believe that is sustainable.
Test pending
made Jul 30, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
At the end of the second quarter, we had $400 million remaining under our current share repurchase program, which we expect to complete by the end of the year.
Test pending
made Jul 30, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
We expect EPS growth to moderate as we lap the lower share count associated with the 2024 accelerated share repurchase program and the benefit of the MSA legal fund expiration.
Test pending
eps · made Jul 30, 2025 · due Dec 31, 2025
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
We still have that as a goal of the way we're managing our business, Bonnie. And when you think about it, it's a mid-single-digit CAGR across that period.
WHAT TO LOOK FOR
Adjusted diluted EPS growth, cumulative annual growth rate (CAGR) from FY2023/FY2024 base year through FY2028
EPS CAGR over the period falls within 4%-6% (mid-single-digit) SourceWHERE TO FIND ITCompany adjusted EPS figures disclosed in quarterly earnings releases and 10-K filings (FY2028 10-K / Q4 FY2028 call)

KNOWABLE AFTER2029-02-15
eps · made Jul 30, 2025 · for FY2028
2025 Q2 (6)6 open
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
So while certain materials may be impacted, for example, tin and aluminum that are used in some of our packaging, the impact on our costs are limited, especially compared to other CPG companies and other industries.
Test pending
made Apr 29, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
You started to see that in the fourth quarter of last year. That will continue. So on a comparative basis, you will see that benefit in the first three quarters of this year.
Test pending
made Apr 29, 2025 · due Sep 30, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
In addition, our guidance range contemplates limited impact of increased tariffs on our costs and potential impacts on our consumers.
Test pending
made Apr 29, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
Our guidance assumes limited impact on combustible and e-vapor product volumes from enforcement efforts in the illicit e-vapor market and assumes NJOY ACE does not return to the marketplace this year.
Test pending
made Apr 29, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
At the end of the first quarter, we had $674 million remaining under our current share repurchase program, which we expect to complete by the end of the year.
Test pending
made Apr 29, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
This year, Helix plans to maintain this momentum by bringing the It's ON! campaign to more consumers and focusing on equity investments behind the ON! brand in new and existing channels.
Test pending
made Apr 29, 2025 · due Dec 31, 2025
2025 Q1 (3)3 open
2024 Q4 (8)8 open
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
We reaffirm our guidance to deliver 2024 full-year adjusted diluted EPS in a range of $5.07 to $5.15, representing a growth rate of 2.5% to 4% from a base of $4.95 in 2023.
Test pending
eps · made Oct 31, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.regulationCONVICTIONStated expectation · “we expect”, “should”, “we see”
We look to file a combined PMTA MRTP in the first half of 2025.
Test pending
made Oct 31, 2024 · due Jun 30, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
At the end of the third quarter, we had $310 million remaining under our current share repurchase program, which we expect to complete by the end of the year.
Test pending
made Oct 31, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
With the initial cost being recorded beginning in the fourth quarter of 2024.
Test pending
made Oct 31, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
Although we are still evaluating certain aspects of the initial phases of the initiative, we expect to record the majority of the cost as special items excluded from adjusted EPS by the end of the first half of 2025.
Test pending
eps · made Oct 31, 2024 · due Jun 30, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
We estimate total pretax charges for the initial phases of approximately $100 million to $125 million.
Test pending
made Oct 31, 2024 · due Jun 30, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
NJOY plans to continue testing trial focused investments with a view toward long-term profitability.
Test pending
made Oct 31, 2024 · due Dec 31, 2025
OPENVERDICTDeadline not reached yet; the claim is still on the clock.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
We expect the initial phases of the initiative will deliver at least $600 million in cumulative cost savings over the next five years, which we plan to reinvest in our businesses in support of our vision and enterprise goals.
WHAT TO LOOK FOR
Cumulative cost savings disclosed from the modernization/efficiency initiative since its Q4 2024 launch
Cumulative disclosed cost savings >= $600 million over the five-year period SourceWHERE TO FIND ITCompany management commentary / investor presentations and 10-K disclosures on the initiative's cumulative savings (MO quarterly earnings calls and filings)

KNOWABLE AFTER2029-10-31
made Oct 31, 2024 · for FY2029
2024 Q3 (8)8 open
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
And we believe our dedicated teams have us on track to deliver against full year financial guidance.
Test pending
eps · made Jul 31, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
You are correct. The total legal fund is about $500 million. We pay our fair share of that based on shipments and you'll get a 1/4 of that this year in the remaining three quarters in 2025.
Test pending
made Jul 31, 2024 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
So we have a base inflation rate for MSA of at least 3%.
Test pending
made Jul 31, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
But volumes are down and that will drive controllable costs up on a per pack basis.
Test pending
made Jul 31, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
In the second half of the year, there are some tailwinds that we expect to see. Some have already mentioned, right, the two extra shipping days that occurred in the back half of the year, the expiration of the legal fund in the fourth quarter.
Test pending
operating_margin · made Jul 31, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
At the end of the quarter, we had approximately $1 billion remaining under our currently authorized share repurchase program which we expect to complete by the end of this year.
Test pending
made Jul 31, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
For 2024, adjusted diluted EPS growth weighted to the second half due to the timing of the NJOY acquisition in June 2023 and the impact of two additional shipping days in the second half of the year.
Test pending
eps · made Jul 31, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
We plan to continue investing behind NJOY's value proposition and equity to build awareness and generate trial.
Test pending
made Jul 31, 2024 · due Dec 31, 2024
2024 Q2 (10)10 open
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
The smokeable segment will continue to benefit from those lower SG&A costs as the year progresses.
Test pending
made Apr 25, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
After the completion of the ASR Program, we anticipate having $1 billion remaining under the currently authorized share repurchase program, which we expect to complete by year-end.
Test pending
made Apr 25, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
We also expect this segment to benefit from lower SG&A costs as the year progresses.
Test pending
made Apr 25, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
Year-over-year MSA and manufacturing cost per pack increases were higher in the first quarter than we expect for the remainder of the year.
Test pending
made Apr 25, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
As we previously noted, we expect that 2024 adjusted diluted EPS growth will be weighted to the second half of the year, resulting from two main factors.
Test pending
eps · made Apr 25, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.regulationCONVICTIONStated expectation · “we expect”, “should”, “we see”
Helix is also making final preparations for following its PMTA for on! PLUS, which we expect to submit in the first half of this year.
Test pending
made Apr 25, 2024 · due Jun 30, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.regulationCONVICTIONStated expectation · “we expect”, “should”, “we see”
We also continue to expect that NJOY will submit PMTA filings for flavored NJOY ACE products with age-gated Bluetooth technology by the end of the second quarter.
Test pending
made Apr 25, 2024 · due Jun 30, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.productCONVICTIONStated expectation · “we expect”, “should”, “we see”
And we expect the majority of fixture resets to be completed in the first half of this year.
Test pending
made Apr 25, 2024 · due Jun 30, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
In the first quarter, we broadened NJOY's distribution to over 80,000 stores. And we expect to expand to approximately 100,000 stores by year-end.
Test pending
made Apr 25, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONHedged language · “we hope”, “could”, “if conditions allow”
Upon FDA authorization, we believe it will contribute meaningfully to Helix' growth.
Test pending
made Apr 25, 2024 · due Dec 31, 2024
2024 Q1 (7)7 open
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capital allocationCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
As far as the NJOY, certainly, you can expect more investment in 2024 than you did in 2023.
Test pending
made Feb 1, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
Our guidance includes the impact of two additional shipping days in 2024 and assumes limited impact from illicit e-vapor enforcement on combustible and e-vapor volumes.
Test pending
made Feb 1, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
We expect 2024 adjusted diluted EPS growth to be weighted to the second half of the year.
Test pending
eps · made Feb 1, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.productCONVICTIONStated expectation · “we expect”, “should”, “we see”
We remain on-track to follow-up PMTA for Ploom in the first half of 2025.
Test pending
made Feb 1, 2024 · due Jun 30, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.productCONVICTIONStated expectation · “we expect”, “should”, “we see”
Our teams are on-track to submit the PMTA for on! PLUS in the first half of this year and upon FDA authorization, we expect it will contribute meaningfully to Helix's growth.
Test pending
made Feb 1, 2024 · due Jun 30, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.productCONVICTIONStated expectation · “we expect”, “should”, “we see”
We expect to further expand, NJOY promotions and marketing activations in the first quarter, and we anticipate submitting a PMTA for NJOY's age restricted Bluetooth device with non-tobacco flavors in the first half of this year.
Test pending
made Feb 1, 2024 · due Jun 30, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capacityCONVICTIONStated expectation · “we expect”, “should”, “we see”
We now expect to have capacity to support our expansion plans for NJOY moving forward.
Test pending
made Feb 1, 2024 · due Dec 31, 2024
2023 Q4 (6)6 open
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.productCONVICTIONStated expectation · “we expect”, “should”, “we see”
And I highlighted the equity campaign is really establishing the brand equity for NJOY and being able to unveil that as we progress into the New Year for the consumer.
Test pending
made Oct 26, 2023 · due Mar 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.productCONVICTIONStated expectation · “we expect”, “should”, “we see”
But we're in the midst of selling in our trade program, which we think is a sustainable position on the retail fixture at retail. That will take place as we progress into the New Year.
Test pending
made Oct 26, 2023 · due Mar 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
As of the end of the quarter, we had $268 million remaining under our current share repurchase program, which we expect to complete by the end of the year.
Test pending
made Oct 26, 2023 · due Dec 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.productCONVICTIONStated expectation · “we expect”, “should”, “we see”
We expect to equity campaign to further amplify the brand's presence at retail and drive consumer engagement with the brand.
Test pending
made Oct 26, 2023 · due Jun 30, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.productCONVICTIONStated expectation · “we expect”, “should”, “we see”
As we continue to expand distribution and close inventory gaps, we expect to further enhance visibility and product fixture space at retail.
Test pending
made Oct 26, 2023 · due Mar 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
During the fourth quarter, we continue to expect ACE expansion to reach a total of 70,000 stores by year-end, representing approximately 70% of e-vapor volume and 55% of cigarette volume sold in the US multi outlet and convenience channel.
Test pending
made Oct 26, 2023 · due Dec 31, 2023
2023 Q3 (5)5 open
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.productCONVICTIONStated expectation · “we expect”, “should”, “we see”
Certainly we'll be, as I mentioned, really enhancing the brand equity to increase awareness amongst both adult vapors and adult cigarette consumers, and then we'll be looking for distribution.
Test pending
made Aug 1, 2023 · due Dec 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
Well, certainly we've highlighted for you Bonnie that we'll be investing behind the NJOY brand as we expand distribution and have equity spending.
Test pending
made Aug 1, 2023 · due Dec 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
At the end of June, we had $528 million remaining under the currently authorized $1 billion share repurchases program, which we expect to complete by the end of this year.
Test pending
made Aug 1, 2023 · due Dec 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
Helix is focused on strategically investing behind this brand as their [effort] (ph) grows and continues to expect profitability in 2025.
Test pending
made Aug 1, 2023 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.productCONVICTIONHedged language · “we hope”, “could”, “if conditions allow”
From a standpoint of the age restriction I think you were referring to, you know we just recently closed it and we're assessing the timing of following that. You know we would have a target in mind by the end of this year.
Test pending
made Aug 1, 2023 · due Dec 31, 2023
2023 Q2 (8)8 open
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.productCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
These products are intended to bolster the offerings within the Marlboro Black family of products and will be available nationwide, beginning in May.
Test pending
made Apr 27, 2023 · due May 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
This range represents an adjusted diluted EPS growth rate of 3% to 6% from a $4.84 base in 2022 and excludes the potential financial impacts of the pending NJOY transaction.
Test pending
eps · made Apr 27, 2023 · due Dec 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
With these things in mind, we reaffirm our guidance to deliver 2023 full year adjusted diluted EPS in a range of $4.98 to $5.13.
Test pending
eps · made Apr 27, 2023 · due Dec 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
As of March 31st, we had $1 billion remaining under the current share repurchase program, which we expect to complete by the end of this year.
Test pending
made Apr 27, 2023 · due Dec 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
And as part of the IQOS agreement we announced last fall, we expect to receive the remaining $1.7 billion plus interest from Philip Morris International by July of this year.
Test pending
made Apr 27, 2023 · due Jul 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
Helix is continuing its focus while strategically investing behind the brand as the category grows and remains committed to achieving profitability in 2025.
Test pending
made Apr 27, 2023 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
We are off to a strong start and believe our businesses are on track to deliver against full year plans.
Test pending
made Apr 27, 2023 · due Dec 31, 2023
OPENVERDICTDeadline not reached yet; the claim is still on the clock.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
We demonstrated this commitment in the first quarter, by paying approximately $1.7 billion in dividends and announcing a new progressive dividend goal that targets mid-single-digit dividend growth annually through 2028.
WHAT TO LOOK FOR
Annual dividend per share growth rate
Dividend per share growth mid-single-digit (approximately 4-6%) annually, each year through 2028 SourceWHERE TO FIND ITCompany dividend announcements / 10-K disclosures on dividends declared per share

KNOWABLE AFTER2028-12-31
made Apr 27, 2023 · for FY2028
2023 Q1 (7)7 open
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
You are correct to point out that when you think about inflation related to MSA, there’s 3% floor. So, even if inflation were measured below 3%, there’d be a 3% increase in the MSA expense.
Test pending
made Feb 1, 2023 · due Dec 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
So, we’re going to spend while -- and invest while the overall category is growing, so we can participate in that growth.
Test pending
made Feb 1, 2023 · due Dec 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.macro economyCONVICTIONStated expectation · “we expect”, “should”, “we see”
So, we have considered that when you think about 2023, there will be an elevated level of inflation. We have seen some receding of the rate of inflation, but still expect it to be elevated.
Test pending
cpi · made Feb 1, 2023 · due Dec 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
But yes, I would say that would be a headwind as we enter 2023.
Test pending
made Feb 1, 2023 · due Dec 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.regulationCONVICTIONStated expectation · “we expect”, “should”, “we see”
Certainly, it will be a headwind from the State of California having banned it.
Test pending
made Feb 1, 2023 · due Dec 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
Earlier this week, our Board authorized a new $1 billion share repurchase program, which we expect to complete by the end of 2023.
Test pending
made Feb 1, 2023 · due Dec 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.productCONVICTIONStated expectation · “we expect”, “should”, “we see”
But going forward, we expect to expand the program to include on! and other smoke-free brands.
Test pending
made Feb 1, 2023 · due Dec 31, 2023
2022 Q4 (3)3 open
2022 Q3 (3)3 open
2022 Q2 (7)7 open
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
We feel comfortable reaffirming our guidance in the quarter.
Test pending
eps · made Apr 28, 2022 · due Dec 31, 2022
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
This range represents an adjusted diluted EPS growth rate of 4% to 7% from $4.61 base in 2021.
Test pending
eps · made Apr 28, 2022 · due Dec 31, 2022
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
We reaffirm our guidance to deliver 2022 full year adjusted diluted EPS in a range of $4.79 to $4.93.
Test pending
eps · made Apr 28, 2022 · due Dec 31, 2022
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
We continue to expect that 2022 adjusted diluted EPS growth will be weighted toward the second half of the year.
Test pending
eps · made Apr 28, 2022 · due Dec 31, 2022
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
We have approximately $1.2 billion remaining under the currently authorized $3.5 billion share repurchase program, which we expect to complete by year-end.
Test pending
made Apr 28, 2022 · due Dec 31, 2022
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
We're off to a strong start to the year and believe our businesses are on track to deliver against their full year plans.
Test pending
made Apr 28, 2022 · due Dec 31, 2022
OPENVERDICTDeadline not reached yet; the claim is still on the clock.otherCONVICTIONStated expectation · “we expect”, “should”, “we see”
When the project is operational, we expect we will hit those targets ahead of schedule.
WHAT TO LOOK FOR
Percentage of purchased electricity from renewable sources and operational greenhouse gas emissions reduction versus baseline, as disclosed in ESG/sustainability reporting
100% renewable electricity achieved and/or 55% GHG emissions reduction achieved before fiscal year 2030 (i.e., ahead of the 2030 target date) SourceWHERE TO FIND ITCompany ESG/sustainability report or CSR disclosures (altria.com), earnings call commentary

KNOWABLE AFTER2030-12-31
made Apr 28, 2022 · for FY2029
2022 Q1 (6)6 open
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.competitionCONVICTIONStated expectation · “we expect”, “should”, “we see”
We expect fluctuation in discount segment shares to continue as the cohort of price-sensitive consumers react to their short-term economic conditions.
Test pending
made Jan 27, 2022 · due Jun 30, 2022
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.competitionCONVICTIONStated expectation · “we expect”, “should”, “we see”
But we do expect quarterly fluctuations in share to continue until the economy begins to stabilize from the pandemic.
Test pending
made Jan 27, 2022 · due Jun 30, 2022
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
Our guidance includes anticipated inflationary increases in master settlement agreement expenses and direct materials expenses and our current expectation that we will not have access to the IQOS system in 2022.
Test pending
made Jan 27, 2022 · due Dec 31, 2022
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
We expect 2022 adjusted diluted EPS growth to be weighted toward the second half of the year.
Test pending
eps · made Jan 27, 2022 · due Dec 31, 2022
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.productCONVICTIONStated expectation · “we expect”, “should”, “we see”
At the present time, we do not expect to have access to IQOS devices or Marlboro HeatSticks in 2022.
Test pending
made Jan 27, 2022 · due Dec 31, 2022
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.regulationCONVICTIONStated expectation · “we expect”, “should”, “we see”
We are also working -- actively working on modified risk tobacco product applications for on! and expect to submit these applications to the FDA by the end of this year.
Test pending
made Jan 27, 2022 · due Dec 31, 2022
2021 Q4 (3)3 open